Detalles de la búsqueda
1.
The economic and humanistic burden of bipolar disorder in adults in the United States.
Ann Gen Psychiatry
; 22(1): 13, 2023 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36964564
2.
Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
BMC Psychiatry
; 21(1): 249, 2021 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975574
3.
Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Curr Ther Res Clin Exp
; 94: 100629, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34306269
4.
Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis.
Chron Respir Dis
; 17: 1479973119901234, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31984767
5.
Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.
COPD
; 16(2): 140-151, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31215259
6.
Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
Int J Chron Obstruct Pulmon Dis
; 17: 559-568, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313719
7.
Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis.
Curr Med Res Opin
; 38(9): 1613-1619, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699377
8.
Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia.
Schizophr Res Cogn
; 28: 100233, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35004189
9.
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis.
J Med Econ
; 25(1): 152-159, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35037813
10.
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population.
J Med Econ
; 25(1): 87-98, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34913797
11.
Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US.
Curr Med Res Opin
; 38(3): 469-478, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812100
12.
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics.
Am J Manag Care
; 28(9): e315-e324, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121363
13.
The Economic Burden of Schizophrenia in the United States.
J Clin Psychiatry
; 83(6)2022 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36244006
14.
Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study.
J Med Econ
; 24(1): 1212-1220, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34647502
15.
Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis.
J Med Econ
; 24(1): 1-9, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143516
16.
Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine.
J Med Econ
; 24(1): 352-362, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588674
17.
Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data.
Curr Med Res Opin
; 37(5): 839-846, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682547
18.
Clinical Characterization of Nursing Facility Residents With Chronic Obstructive Pulmonary Disease.
Sr Care Pharm
; 36(5): 248-257, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33879286
19.
Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies.
Int J Chron Obstruct Pulmon Dis
; 15: 2309-2318, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061349
20.
Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis.
Medicine (Baltimore)
; 99(25): e20718, 2020 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32569208